8 active warrant series; nearest expiry 2027-03-05.
Compare this book against every issuer →8 option grants covering 848,335 shares (~1.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $6.16 | Mar 5, 2027 158d | 15K | ITM | 0.0% | C$92K | Auto |
| option | $7.83 | Mar 8, 2028 527d | 50K | ITM | 0.1% | C$392K | Auto |
| option | $9.17 | Mar 9, 2029 893d | 117K | ITM | 0.3% | C$1.1M | Auto |
| option | $9.23 | Mar 9, 2029 893d | 92K | ITM | 0.2% | C$846K | Auto |
| option | $8.71 | Mar 9, 2030 1258d | 150K | ITM | 0.3% | C$1.3M | Auto |
| option | $8.53 | Mar 9, 2030 1258d | 125K | ITM | 0.3% | C$1.1M | Auto |
| option | $12.01 | Mar 5, 2031 1619d | 150K | ITM | 0.3% | C$1.8M | Auto |
| option | $11.90 | Mar 5, 2031 1619d | 150K | ITM | 0.3% | C$1.8M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
45,764,404 shares outstanding, plus 0 from warrants and 848,335 from options — a fully diluted 46,612,739 shares, or ~1.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
8 active warrant series; nearest expiry 2027-03-05.
Compare this book against every issuer →8 option grants covering 848,335 shares (~1.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $6.16 | Mar 5, 2027 158d | 15K | ITM | 0.0% | C$92K | Auto |
| option | $7.83 | Mar 8, 2028 527d | 50K | ITM | 0.1% | C$392K | Auto |
| option | $9.17 | Mar 9, 2029 893d | 117K | ITM | 0.3% | C$1.1M | Auto |
| option | $9.23 | Mar 9, 2029 893d | 92K | ITM | 0.2% | C$846K | Auto |
| option | $8.71 | Mar 9, 2030 1258d | 150K | ITM | 0.3% | C$1.3M | Auto |
| option | $8.53 | Mar 9, 2030 1258d | 125K | ITM | 0.3% | C$1.1M | Auto |
| option | $12.01 | Mar 5, 2031 1619d | 150K | ITM | 0.3% | C$1.8M | Auto |
| option | $11.90 | Mar 5, 2031 1619d | 150K | ITM | 0.3% | C$1.8M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
45,764,404 shares outstanding, plus 0 from warrants and 848,335 from options — a fully diluted 46,612,739 shares, or ~1.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
